Lipps, Christoph
Klein, Franziska
Wahlicht, Tom
Seiffert, Virginia
Butueva, Milada
Zauers, Jeannette
Truschel, Theresa
Luckner, Martin
Köster, Mario
MacLeod, Roderick
Pezoldt, Jörn http://orcid.org/0000-0001-7143-5691
Hühn, Jochen
Yuan, Qinggong
Müller, Peter Paul
Kempf, Henning
Zweigerdt, Robert http://orcid.org/0000-0002-4656-0770
Dittrich-Breiholz, Oliver
Pufe, Thomas
Beckmann, Rainer
Drescher, Wolf
Riancho, Jose
Sañudo, Carolina
Korff, Thomas
Opalka, Bertram
Rebmann, Vera
Göthert, Joachim R.
Alves, Paula M.
Ott, Michael
Schucht, Roland
Hauser, Hansjörg
Wirth, Dagmar
May, Tobias http://orcid.org/0000-0002-4042-4815
Article History
Received: 30 October 2015
Accepted: 9 February 2018
First Online: 8 March 2018
Competing interests
: T. M., H.H.A., F.K., R.S., and J.Z. filed a patent for the technology described in this work (International patent application WO/2012/059223). T.M. and R.S. are shareholders of InSCREENeX GmbH, which commercializes immortalized cell lines developed by the technology described in this work. T.M., R.S., J.Z., T.T., and M.L. are employees of InSCREENeX GmbH. The remaining authors declare no competing interests.